Cargando…
Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects
Omaveloxolone (RTA408) is a second-generation oleanane triterpenoid Nrf2 inducer with antioxidant and anti-inflammatory properties and was reported to improve mitochondrial bioenergetics. It is currently being tested in medical trials for Friedrich ataxia, a genetic, multi-organ disease involving mi...
Autores principales: | Zighan, Madleen, Arkadir, David, Douiev, Liza, Keller, Guy, Miller, Chaya, Saada, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411646/ https://www.ncbi.nlm.nih.gov/pubmed/36032663 http://dx.doi.org/10.3389/fmolb.2022.890653 |
Ejemplares similares
-
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
por: Creelan, Ben C, et al.
Publicado: (2017) -
Replicative Stress Coincides with Impaired Nuclear DNA Damage Response in COX4-1 Deficiency
por: Douiev, Liza, et al.
Publicado: (2022) -
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
por: Probst, Brandon L., et al.
Publicado: (2015) -
The Effects of Ascorbate, N-Acetylcysteine, and Resveratrol on Fibroblasts from Patients with Mitochondrial Disorders
por: Douiev, Liza, et al.
Publicado: (2016) -
Upregulation of COX4-2 via HIF-1α in Mitochondrial COX4-1 Deficiency
por: Douiev, Liza, et al.
Publicado: (2021)